Suppr超能文献

常年性减敏治疗期间针对变应原分子的特异性IgE反应:一项为期三年的前瞻性双盲研究。

Specific IgE response toward allergenic molecules during perennial hyposensitization: a three-year prospective double-blind study.

作者信息

Osterballe O, Ipsen H, Weeke B, Løwenstein H

出版信息

J Allergy Clin Immunol. 1983 Jan;71(1 Pt 1):40-6. doi: 10.1016/0091-6749(83)90545-6.

Abstract

Allergenic extracts are multicomponent systems containing a number of potentially allergenic molecules. In a 3 yr prospective double-blind study, sera from 40 patients hyposensitized with either a two-component timothy extract or a 20-component timothy extract were evaluated by means of crossed radioimmunoelectrophoresis. The patients exhibited specific IgE response toward individual allergenic molecules, and IgE with new specificities did not develop after hyposensitization. A high degree of clinical protection could generally be obtained on treatment with the 20-component timothy extract, but this was true only with the two-component timothy extract containing the allergenic molecules that matched the individual IgE response.

摘要

变应原提取物是包含许多潜在变应原分子的多组分系统。在一项为期3年的前瞻性双盲研究中,通过交叉放射免疫电泳对40例用两组分梯牧草提取物或20组分梯牧草提取物进行减敏治疗的患者的血清进行了评估。患者对单个变应原分子表现出特异性IgE反应,减敏治疗后未产生具有新特异性的IgE。一般来说,用20组分梯牧草提取物治疗可获得高度的临床保护作用,但只有含与个体IgE反应相匹配的变应原分子的两组分梯牧草提取物才是如此。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验